4.7 Article

Telemedicine Can Replace the Neurologist on a Mobile Stroke Unit

期刊

STROKE
卷 48, 期 2, 页码 493-496

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/STROKEAHA.116.015363

关键词

ambulance; emergency medical services; stroke; telemedicine; tissue-type plasminogen activator

资金

  1. American Heart Association

向作者/读者索取更多资源

Background and Purpose-The BEST-MSU study (Benefits of Stroke Treatment Delivered Using a Mobile Stroke Unit) is a comparative effectiveness trial in patients randomized to mobile stroke unit or standard management. A substudy tested interrater agreement for tissue-type plasminogen activator eligibility between a telemedicine vascular neurologist and onboard vascular neurologist. Methods-On scene, both the telemedicine vascular neurologist and onboard vascular neurologist independently evaluated the patient, documenting their tissue-type plasminogen activator treatment decision, National Institutes of Health Stroke Scale score, and computed tomographic interpretation. Agreement was determined using Cohen statistic. Telemedicine-related technical failures that impeded remote assessment were recorded. Results-Simultaneous and independent telemedicine vascular neurologist and onboard vascular neurologist assessment was attempted in 174 patients. In 4 patients (2%), the telemedicine vascular neurologist could not make a decision because of technical problems. The telemedicine vascular neurologist agreed with the onboard vascular neurologist on 88% of evaluations (kappa=0.73). Conclusions-Remote telemedicine vascular neurologist assessment is reliable and accurate, supporting either telemedicine vascular neurologist or onboard vascular neurologist assessment on our mobile stroke unit.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Rehabilitation

Characteristics of Acute Stroke Patients Readmitted to Inpatient Rehabilitation Facilities: A Cohort Study

Nneka L. Ifejika, Minal Bhadane, Chunyan C. Cai, Jeffrey N. Watkins, James C. Grotta

Summary: The study found that patients with hemorrhagic stroke, non-Medicare insurance, or lower discharge FIM score during the first IRF hospitalization are more likely to require a second IRF stay.
Article Peripheral Vascular Disease

Blood pressure excursions in acute ischemic stroke patients treated with intravenous thrombolysis

Georgios Tsivgoulis, Aristeidis H. Katsanos, Pitchaiah Mandava, Martin Kohrmann, Lauri Soinne, Andrew D. Barreto, Vijay K. Sharma, Robert Mikulik, Keith W. Muir, Travis Rothlisberger, James C. Grotta, Christopher R. Levi, Carlos A. Molina, Maher Saqqur, Dimitris Mavridis, Theodora Psaltopoulou, Milan R. Vosko, Jochen B. Fiebach, Else Charlotte Sandset, Thomas A. Kent, Anne W. Alexandrov, Peter D. Schellinger, Andrei Alexandrov

Summary: The study found that blood pressure excursions in patients with acute ischemic stroke treated with tPA were common and independently associated with adverse clinical outcomes.

JOURNAL OF HYPERTENSION (2021)

Article Clinical Neurology

Integrated Stroke System Model Expands Availability of Endovascular Therapy While Maintaining Quality Outcomes

Victor Lopez-Rivera, Sergio Salazar-Marioni, Rania Abdelkhaleq, Sean Savitz, Alexandra L. Czap, Yazan J. Alderazi, Peng R. Chen, James C. Grotta, Spiros L. Blackburn, Wesley Jones, Gary Spiegel, Mark J. Dannenbaum, Tzu-Ching Wu, Joseph Cochran, Dong H. Kim, Arthur L. Day, Grace Farquhar, Louise D. McCullough, Sunil A. Sheth

Summary: The study demonstrates that increasing endovascular stroke therapy (EVT) availability through the implementation of an integrated stroke system (ISS) decreases the time from stroke onset to EVT-performing hospital (EPH) arrival. Following the implementation of ISS, the proportion of patients undergoing interhospital transfer decreased. Results show that ISS implementation resulted in a reduction of treatment time, with comparable outcomes in quality metrics at high and low volume hospitals.

STROKE (2021)

Article Cell & Tissue Engineering

Longitudinal neuroimaging evaluation of the corticospinal tract in patients with stroke treated with autologous bone marrow cells

Muhammad E. Haque, Khader M. Hasan, Sarah George, Clark Sitton, Seth Boren, Octavio D. Arevalo, Farhaan Vahidy, Xu Zhang, Charles S. Cox, Susan Alderman, Jaroslaw Aronowski, James C. Grotta, Sean Savitz

Summary: The study demonstrates that bone marrow mononuclear cells (MNCs) can attenuate secondary degeneration and enhance recovery in stroke animal models. MRI imaging showed that treated patients with larger infarcts and higher stroke severity exhibited an increase in relative FA and no change in relative MD from 3 to 12 months, which was not observed in the nontreated group.

STEM CELLS TRANSLATIONAL MEDICINE (2021)

Article Cardiac & Cardiovascular Systems

Utilization and Availability of Advanced Imaging in Patients With Acute Ischemic Stroke

Youngran Kim, Songmi Lee, Rania Abdelkhaleq, Victor Lopez-Rivera, Babak Navi, Hooman Kamel, Sean Savitz, Alexandra L. Czap, James C. Grotta, Louise D. McCullough, Trudy Millard Krause, Luca Giancardo, Farhaan S. Vahidy, Sunil A. Sheth

Summary: In statewide and national Medicare fee-for-service cohorts, the utilization of CTP in patients with AIS was low and most patients were evaluated at hospitals that did not perform CTP. These findings suggest a need for alternative screening methods for AIS recanalization therapies.

CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2021)

Article Clinical Neurology

The Story of Intracerebral Hemorrhage From Recalcitrant to Treatable Disease

Joseph P. Broderick, James C. Grotta, Andrew M. Naidech, Thorsten Steiner, Nikola Sprigg, Kazunori Toyoda, Dar Dowlatshahi, Andrew M. Demchuk, Magdy Selim, J. Mocco, Stephan Mayer

Summary: Research in the acute management of intracerebral hemorrhage (ICH) over the past 35 years has shown that early treatment to control bleeding and minimize brain injury is crucial. However, current medical and surgical interventions have not yet shown significant benefits in large-scale trials, emphasizing the need for further research and improvement in the delivery of ICH therapies for better outcomes.

STROKE (2021)

Editorial Material Clinical Neurology

Complexities of Reperfusion Therapy in Patients With Ischemic Stroke Pretreated With Direct Oral Anticoagulants To Treat or Not, and How?

Alexandra L. Czap, James C. Grotta

Summary: This Viewpoint discusses the challenges of using thrombolysis in patients with acute ischemic stroke who are on or have recently been treated with direct oral anticoagulants.

JAMA NEUROLOGY (2021)

Article Health Care Sciences & Services

Leveraging Multimedia Patient Engagement to Address Minority Cerebrovascular Health Needs: Prospective Observational Study

Elizabeth Anne Noser, Jing Zhang, Mohammad Hossein Rahbar, Anjail Zarinah Sharrief, Andrew David Barreto, Sandi Shaw, James Charles Grotta, Sean Isaac Savitz, Nneka Lotea Ifejika

Summary: The Stomp Out Stroke initiative addressed social inequities in cerebrovascular health by identifying race- or ethnicity-specific health needs and providing appropriate screenings to minority populations. Through internet-based recruitment and in-person assessments, the project reached a significant number of individuals in the Houston area at increased risk of urban flooding and stroke.

JOURNAL OF MEDICAL INTERNET RESEARCH (2021)

Article Medicine, General & Internal

Prospective, Multicenter, Controlled Trial of Mobile Stroke Units

J. C. Grotta, J. Yamal, S. A. Parker, S. S. Rajan, N. R. Gonzales, W. J. Jones, A. W. Alexandrov, B. B. Navi, M. Nour, I Spokoyny, J. Mackey, D. Persse, A. P. Jacob, M. Wang, N. Singh, A. Alexandrov, M. E. Fink, J. L. Saver, J. English, N. Barazangi, P. L. Bratina, M. Gonzalez, B. D. Schimpf, K. Ackerson, C. Sherman, M. Lerario, S. Mir, J. Im, J. Z. Willey, D. Chiu, M. Eisshofer, J. Miller, D. Ornelas, J. P. Rhudy, K. M. Brown, B. M. Villareal, M. Gausche-Hill, N. Bosson, G. Gilbert, S. Q. Collins, K. Silnes, J. Volpi, V Misra, J. McCarthy, T. Flanagan, C. P. Rao, J. S. Kass, L. Griffin, N. Rangel-Gutierrez, E. Lechuga, J. Stephenson, K. Phan, Y. Sanders, E. A. Noser, R. Bowry

Summary: In patients eligible for t-PA, mobile stroke units (MSUs) showed better functional outcomes at 90 days compared to emergency medical services (EMS). Patients in the MSU group were more likely to achieve a modified Rankin scale score of 0 or 1 at 90 days.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Clinical Neurology

Hemorrhage Enlargement Is More Frequent in the First 2 Hours: A Prehospital Mobile Stroke Unit Study

Ritvij Bowry, Stephanie A. Parker, Patti Bratina, Noopur Singh, Jose-Miguel Yamal, Suja S. Rajan, Asha P. Jacob, Kenny Phan, Alexandra Czap, James C. Grotta

Summary: This study found that patients with intracerebral hemorrhage (ICH) who underwent baseline imaging within the first hour after symptom onset had a higher risk of hematoma enlargement (HE), making them a target for ultraearly hemostatic intervention.

STROKE (2022)

Letter Clinical Neurology

Thromboelastography Indices for Predicting Outcomes After Aneurysmal Subarachnoid Hemorrhage: A Prospective Study

Hussein A. Zeineddine, Wen Li, Peeyush T. Kumar, Devin McBride, Ari Dienel, Glenda Torres, James Grotta, Jude Savarraj, Tiffany Chang, Huimahn A. Choi, Pramod Dash, Spiros Blackburn

STROKE (2022)

Review Clinical Neurology

Prophylactic Therapies for Morbidity and Modality After Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Network Meta-Analysis of Randomized Trials

Mojtaba Dayyani, Behnam Sadeghirad, James C. Grotta, Samira Zabihyan, Saba Ahmadvand, Yuting Wang, Gordon H. Guyatt, Sepideh Amin-Hanjani

Summary: Network meta-analysis showed that nimodipine and cilostazol were likely the most effective treatments in preventing morbidity and mortality in patients with aneurysmal subarachnoid hemorrhage. Clazosentan, nicardipine, fasudil, and magnesium showed beneficial effects on delayed cerebral ischemia and vasospasm but they were not found to reduce mortality or disability.

STROKE (2022)

Review Clinical Neurology

Mobile Stroke Units: Evidence, Gaps, and Next Steps

Babak B. Navi, Heinrich J. Audebert, Anne W. Alexandrov, Dominique A. Cadilhac, James C. Grotta

Summary: Mobile stroke units (MSUs) are specialized ambulances equipped to diagnose and treat acute stroke in prehospital settings. Recent clinical trials have shown that treatment aboard MSUs is safe and leads to improved functional outcomes. However, questions remain regarding the cost-effectiveness of MSUs, their utility in nonurban settings, and optimal infrastructure.

STROKE (2022)

Article Clinical Neurology

Recruitment in Acute Stroke Trials: Challenges and Potential Solutions

Joseph P. Broderick, Yasmin N. Aziz, Opeolu M. Adeoye, James C. Grotta, Andrew M. Naidech, Andrew D. Barreto, Colin P. Derdeyn, Heidi J. Sucharew, Jordan J. Elm, Pooja Khatri

Summary: Randomized clinical trials of acute stroke have resulted in significant progress in acute stroke therapy, but recruitment of participants remains challenging. In this article, the challenges in recruitment for acute stroke trials are discussed, along with potential solutions to expedite the identification of new treatments. These solutions include expanding the inclusion criteria, improving availability of study investigators, utilizing telemedicine, enhancing prehospital notification, simplifying study protocols, and educating physicians. Successful recruitment is crucial for advancing scientific knowledge and improving clinical outcomes for acute stroke patients.

STROKE (2023)

暂无数据